Daily BriefsUnited States

Daily Brief United States: ZEEKR, Aspira Women’s Health, NOW Inc and more

In today’s briefing:

  • ZEEKR IPO: The Bull Case
  • Aspira Women’s Health, Inc. – Reports 3Q23 Results
  • NOW, Inc. – Resilient Model Withstands Industry Headwinds


ZEEKR IPO: The Bull Case

By Arun George

  • ZEEKR (ZK US), a premium Chinese BEV manufacturer and a subsidiary of Geely Auto (175 HK), has filed for a US$500 million IPO to list on the NYSE.
  • ZEEKR has launched three models – the luxury shooting brake coupe ZEEKR 001, the luxury pure electric MPV – ZEEKR 009 and the new luxury versatile SUV – ZEEKR X.
  • The bull case rests on bestselling premium BEVs, rapid vehicle sales growth, rising gross margin, debt-free balance sheet and a favourable cash conversion cycle.

Aspira Women’s Health, Inc. – Reports 3Q23 Results

By Water Tower Research

  • Aspira Women’s Health reported 3Q23 financial results, mostly in line with our estimates.
  • Revenue of $2.2 million was below our estimate, but good expense control is in place and is expected to continue.
  • Our estimates for 2023 and 2024 remain in line with our prior estimates.

NOW, Inc. – Resilient Model Withstands Industry Headwinds

By Water Tower Research

  • DNOW’s business has been resilient in the face of a declining US rig count through the first three quarters of 2023.
  • 3Q23 US revenue was $448 million, 3% higher than 3Q22 despite an 11% fall in the average rig count.
  • On a per rig basis, US 3Q23 revenue averaged ~$689,000, a 20% Y/Y gain

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars